Stock screener

MNPR

Conviction 60HealthcareScan · Thu, Sep 24, 2026

Monopar Therapeutics (MNPR) closed at $89.03 (-0.39%) on Sep 24, 2026. Price is below its 50-day and above its 200-day moving average. RSI(14) 27, RS Rating 84, -28.1% from its 52-week high, +34.9% year to date. Sector: Healthcare · PHARMACEUTICAL PREPARATIONS.

MNPR$89.03-0.39%
ResistanceSupportVol 14Insider sell
63 bars
13
6
Vol MA14 171.2K
Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24
Monopar TherapeuticsPHARMACEUTICAL PREPARATIONSwww.monopartx.com ↗
Price89.03
Change-0.39%
Gap+1.01%
Rel volume5.09×
Avg volume170.51K
Avg $ vol17.67M
SMA 20106.94
SMA 50110.55
SMA 20076.33
Price vs 50-19.47%
Price vs 200+16.64%
MA stackmixed
50/200 cross—
Supertrenddown · 104.79
RSI (14)27
MACD hist-2.49
MACD cross—
Stoch %K / %D7 / 8
ADX (14)26
+DI / −DI10 / 33
RSI divergence—
MACD divergence—
ATR %6.37%
ADR %4.84%
52w high123.84
52w low50.12
From 52w high-28.11%
Above 52w low+77.63%
New 52w highNo
SqueezeOff
Bollinger width34.27%
%B0.01
Donchian pos6.98%
Donchian high121.02
Donchian low86.63
AVWAP (52w high)109.55
vs AVWAP high-18.73%
AVWAP (52w low)93.61
vs AVWAP low-4.89%
OBV trendDown
Chaikin MF (20)-0.08
Today vs 20d5.09×
Avg vol (14d)171.2K
Avg vol (20d)170.51K
Avg $ vol (20d)17.67M
Market cap597.58M
RS Rating84 / 99
RS 3m (vs SPY)-2.89%
RS 6m (vs SPY)+39.51%
RS line new highNo
Trend template5/8
Technical rank58.7
1 week-13.31%
1 month-19.66%
3 months+1.60%
6 months+56.33%
1 year+31.56%
YTD+34.87%
P/E-43.57
P/B4.57
P/S—
P/FCF—
EPS-0.7300
Div yield—
ROE-10.48%
ROA-10.16%
Debt/Eq—
Current33.56
EV/EBITDA—
Gross margin—
Net margin—
Rev growth—
EPS growth11.99%
Price target123.25
Target upside38.44%
Analyst ratingBuy
Institutional116.73%
Ent. value544.83M
Revenue0
Net income-5.31M
Gross profit—
Free cash flow—
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out6.7M
Employees22
ListedThu, Dec 19, 2019
Free float4.1M
Float %61.4%
Short interest852.42K
Days to cover4.5d
Short volume41.6%
Squeeze score79 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$0.62 vs −$0.67
Last surprise+7.5% beat
Setup gradeB
Conviction60 / 100
Pattern quality—
Tech rank58.7 / 100
Group rank59 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance124.55
Support104.62
Days since event—
Candle confirm—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in MNPR

All disclosures →
No recent disclosed trades by Congress in MNPR. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in MNPR · open-market 6 sells

InsiderSideShares
Tsuchimoto Kim R
Director · Stock Option · 2026-08-26
Exercise2.06K
Tsuchimoto Kim R
Director · Common Stock · 2026-08-26
Sell602
Tsuchimoto Kim R
Director · Common Stock · 2026-08-26
Sell590
Tsuchimoto Kim R
Director · Stock Option · 2026-08-26
Exercise2.04K
Tsuchimoto Kim R
Director · Common Stock · 2026-08-26
Exercise2.06K
Tsuchimoto Kim R
Director · Common Stock · 2026-08-26
Exercise2.04K
Tsuchimoto Kim R
Director · Common Stock · 2026-08-26
Sell485
Tsuchimoto Kim R
Director · Common Stock · 2026-08-26
Sell615
Tsuchimoto Kim R
Director · Common Stock · 2026-08-26
Sell700
Tsuchimoto Kim R
Director · Common Stock · 2026-08-26
Sell1.1K

SEC filings

EDGAR filings in MNPR · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.